{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:43:43Z","timestamp":1793317423533,"version":"4.5.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"38","funder":[{"name":"Zhejiang medical association clinical fund","award":["2019ZYC-A190"],"award-info":[{"award-number":["2019ZYC-A190"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1097\/md.0000000000022004","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T18:06:54Z","timestamp":1600452414000},"page":"e22004","source":"Crossref","is-referenced-by-count":26,"title":["Equimolar doses of hypertonic agents (saline or mannitol) in the treatment of intracranial hypertension after severe traumatic brain injury"],"prefix":"10.1097","volume":"99","author":[{"given":"Xuecai","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinping","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shike","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,9,18]]},"reference":[{"key":"R1-20230103","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s12028-007-0012-1","article-title":"Role of intracranial pressure values and patterns in predicting outcome of traumatic brain injury: a systematic review","volume":"6","author":"Treggiari","year":"2007","journal-title":"Neurocrit Care"},{"issue":"(Suppl 1)","key":"R2-20230103","first-page":"1","article-title":"AANS\/CNS: guidelines for the management of severe traumatic brain injury","volume":"24","year":"2007","journal-title":"J Neurotrauma"},{"key":"R3-20230103","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1227\/NEU.0000000000001432","article-title":"Guidelines for the management of severe traumatic brain injury, fourth edition","volume":"80","author":"Carney","year":"2017","journal-title":"Neurosurgery"},{"key":"R4-20230103","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.3171\/2013.12.JNS13888","article-title":"Increased risk of acute kidney injury associated with higher infusion rate of mannitol in patients with intracranial hemorrhage","volume":"120","author":"Kim","year":"2014","journal-title":"J Neurosurg"},{"key":"R5-20230103","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3171\/jns.1992.77.4.0584","article-title":"Aggravation of vasogenic cerebral edema by multiple-dose mannitol","volume":"77","author":"Kaufmann","year":"1992","journal-title":"J Neurosurg"},{"key":"R6-20230103","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1097\/00000542-199806000-00023","article-title":"Rebound swelling of astroglial cells exposed to hypertonic mannitol","volume":"88","author":"McManus","year":"1998","journal-title":"Anesthesiology"},{"key":"R7-20230103","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF01406742","article-title":"Methodology for the control of intracranial pressure with hypertonic mannitol","volume":"51","author":"James","year":"1980","journal-title":"Acta Neurochir"},{"key":"R8-20230103","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3171\/jns.1978.48.2.0169","article-title":"Mannitol dose requirements in brain injured patients","volume":"48","author":"Marshall","year":"1978","journal-title":"J Neurosurg"},{"key":"R9-20230103","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/neuros\/nyz046","article-title":"Hypertonic saline is superior to mannitol for the combined effect on intracranial pressure and cerebral perfusion pressure burdens in patients with severe traumatic brain injury","volume":"86","author":"Mangat","year":"2020","journal-title":"Neurosurgery"},{"key":"R10-20230103","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3171\/2014.10.JNS132545","article-title":"Hypertonic saline reduces cumulative and daily intracranial pressure burdens after severe traumatic brain injury","volume":"122","author":"Mangat","year":"2015","journal-title":"J Neurosurg"},{"key":"R11-20230103","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1371\/journal.pmed.0050165","article-title":"Predicting outcome after traumatic brain injury: development and international validation of prognostic scores based on admission characteristics","volume":"5","author":"Steyerberg","year":"2008","journal-title":"PLoS Med"},{"key":"R12-20230103","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/CCM.0b013e318206b9be","article-title":"Hypertonic saline vs mannitol for the treatment of elevated intracranial pressure: a meta-analysis of randomized clinical trials","volume":"39","author":"Kamel","year":"2011","journal-title":"Crit Care Med"},{"key":"R13-20230103","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12028-019-00771-y","article-title":"Evidence for mannitol as an effective agent against intracranial hypertension: an individual patient data meta-analysis","volume":"32","author":"Poole","year":"2020","journal-title":"Neurocrit Care"},{"key":"R14-20230103","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1089\/neu.2019.6399","article-title":"Early osmotherapy in severe traumatic brain injury: an international multicentre study","volume":"37","author":"Anstey","year":"2020","journal-title":"J Neurotrauma"},{"key":"R15-20230103","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1089\/neu.2011.1929","article-title":"Comparison of effects of equiosmolar doses of mannitol and hypertonic saline on cerebral blood flow and metabolism in traumatic brain injury","volume":"28","author":"Cottenceau","year":"2011","journal-title":"J Neurotrauma"},{"key":"R16-20230103","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3171\/2010.5.JNS091685","article-title":"Comparison of mannitol and hypertonic saline in the treatment of severe brain injuries","volume":"114","author":"Sakellaridis","year":"2011","journal-title":"J Neurosurg"},{"key":"R17-20230103","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/CCM.0B013E3181643B41","article-title":"Equimolar doses of mannitol and hypertonic saline in the treatment of increased intracranial pressure","volume":"36","author":"Francony","year":"2008","journal-title":"Crit Care Med"},{"key":"R18-20230103","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00134-008-1283-5","article-title":"Sodium lactate vs mannitol in the treatment of intracranial hypertensive episodes in severe traumatic brain-injured patients","volume":"35","author":"ICHai","year":"2009","journal-title":"Intensive Care Med"},{"key":"R19-20230103","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.CCM.0000150269.65485.A6","article-title":"Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline\/6% dextran solution on increased intracranial pressure after brain injury","volume":"33","author":"Battison","year":"2005","journal-title":"Crit Care Med"},{"key":"R20-20230103","first-page":"186","article-title":"Treatment of intraparenchymal hypertension with hyperosmotic therapy: hypertonic saline 7.45% vs. mannitol 20%","volume":"82","author":"Santacruz","year":"2016","journal-title":"Minerva Anestesiol"},{"key":"R21-20230103","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jocn.2015.08.035","article-title":"An equiosmolar study on early intracranial physiology and long term outcome in severe traumatic brain injury comparing mannitol and hypertonic saline","volume":"27","author":"Jagannatha","year":"2016","journal-title":"J Clin Neurosci"},{"key":"R22-20230103","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3171\/2011.7.JNS102142","article-title":"Hypertonic saline for treating raised intracranial pressure: literature review with meta-analysis","volume":"116","author":"Mortazavi","year":"2012","journal-title":"J Neurosurg"},{"key":"R23-20230103","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1097\/CCM.0b013e31827ca4b3","article-title":"High-osmolarity saline in neurocritical care: systematic review and meta-analysis","volume":"41","author":"Lazaridis","year":"2013","journal-title":"Crit Care Med"},{"key":"R24-20230103","first-page":"640","article-title":"Osmotherapy for intracranial hypertension: mannitol vs hypertonic saline","volume":"18","author":"Fink","year":"2012","journal-title":"Continuum (Minneap Minn)"},{"key":"R25-20230103","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3171\/jns.1988.68.3.0478","article-title":"Treatment of resistant intracranial hypertension with hypertonic saline","volume":"68","author":"Worthley","year":"1988","journal-title":"J Neurosurg"},{"key":"R26-20230103","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1080\/01616412.1999.11741010","article-title":"Hypertonic saline solution for control of elevated intracranial pressure in patients with exhausted response to mannitol and barbiturates","volume":"21","author":"Horn","year":"1999","journal-title":"Neurol Res"},{"key":"R27-20230103","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3171\/JNS\/2008\/108\/5\/1010","article-title":"Neurosurgical implications of mannitol accumulation within a meningioma and its peritumoral region demonstrated by magnetic resonance spectroscopy: case report","volume":"108","author":"Sankar","year":"2008","journal-title":"J Neurosurg"},{"key":"R28-20230103","first-page":"63","article-title":"Passage of mannitol into the brain around gliomas: a potential cause of rebound phenomenon. A study on 21 patients","volume":"50","author":"Palma","year":"2006","journal-title":"J Neurosurg Sci"},{"key":"R29-20230103","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00005792-199005000-00003","article-title":"Mannitol-induced acute renal failure","volume":"69","author":"Dorman","year":"1990","journal-title":"Medicine (Baltimore)"},{"key":"R30-20230103","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1681\/ASN.V861028","article-title":"Mannitol-induced renal failure","volume":"8","author":"Visweswaran","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"R31-20230103","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000184124","article-title":"Mannitol-induced acute renal failure","volume":"45","author":"Weaver","year":"1987","journal-title":"Nephron"},{"issue":"(3S Suppl 1)","key":"R32-20230103","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/PCC.0000000000001735","article-title":"Guidelines for the management of pediatric severe traumatic brain injury, third edition: update of the Brain Trauma Foundation guidelines","volume":"20","author":"Kochanek","year":"2019","journal-title":"Pediatr Crit Care Med"},{"key":"R33-20230103","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1212\/01.wnl.0000304042.05557.60","article-title":"Reversal of transtentorial herniation with hypertonic saline","volume":"70","author":"Koenig","year":"2008","journal-title":"Neurology"},{"key":"R34-20230103","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s12028-013-9907-1","article-title":"Safety and efficacy of repeated doses of 14.6 or 23.4% hypertonic saline for refractory intracranial hypertension","volume":"20","author":"Lewandowski-Belfer","year":"2014","journal-title":"Neurocrit Care"},{"key":"R35-20230103","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11011-010-9175-0","article-title":"Central pontine myelinolysis: historical and mechanistic considerations","volume":"25","author":"Norenberg","year":"2010","journal-title":"Metab Brain Dis"}],"updated-by":[{"DOI":"10.1097\/md.0000000000025953","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000}}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T21:39:06Z","timestamp":1672781946000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,18]]},"references-count":35,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000022004","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,18]]}}}